American CryoStem Corporation
CRYO · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $13,641 | $18,728 | $37,479 | $18,149 |
| - Cash | $3 | $23 | $103 | $8 |
| + Debt | $1,168 | $1,183 | $1,126 | $1,151 |
| Enterprise Value | $14,806 | $19,888 | $38,502 | $19,291 |
| Revenue | $43 | $32 | $61 | -$363 |
| % Growth | 33.4% | -47.8% | 116.9% | – |
| Gross Profit | $38 | $29 | $42 | -$368 |
| % Margin | 88.8% | 90.6% | 69.2% | 101.4% |
| EBITDA | -$356 | -$911 | -$340 | -$2,025 |
| % Margin | -834.7% | -2,852.2% | -555.6% | 558.4% |
| Net Income | -$402 | -$964 | -$381 | -$2,062 |
| % Margin | -943% | -3,018% | -622.3% | 568.5% |
| EPS Diluted | -0.009 | -0.022 | -0.007 | -0.034 |
| % Growth | 59.1% | -214.3% | 79.5% | – |
| Operating Cash Flow | -$123 | -$44 | -$532 | $11 |
| Capital Expenditures | -$24 | -$40 | -$10 | -$56 |
| Free Cash Flow | -$147 | -$83 | -$542 | -$45 |